Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

BAR.BR BE Equity

Barco
Euronext Brussels+ CompareTear sheet →
Information Technology · FY ends Dec 31
€7.93
-0.02 (-0.19%)
EUR · as of 2026-08-17 · marketstack
3 registered studies · 1 active

Studies where BAR.BR is the lead sponsor, as filed with ClinicalTrials.gov. Completion dates are the sponsor's own projected windows and are revised as a study runs. Active studies first, then completed and stopped — newest readout first within each.

3 observational

Held by 0 tracked-famous managers · government filings 180d: none disclosed

StudyPhaseStatusInterventionsConditionsEnrollmentPrimary completionUpdated
Research in the Development of a New Type of Digital Dermatoscope for Skin CancerNCT03818620observationalDevelopment of anonymized database with over 3000 (potential) skin cancer cases for use in AIActive, not recruitingDevice: Barco digital dermatoscope device images, Reference standard dermatoscope device imagesSkin Cancer, Skin Diseases3,0002025-04-302025-02-05
Development and Validation of a New Digital Dermatoscope in the United StatesNCT04047316observationalPerformance of the new device in its normal conditions of useCompletedDevice: Digital dermoscopySkin Cancer602020-04-15actual2020-06-18
Utility of Digital Dermoscopy in the Skin Cancer ClinicNCT03497455observationalClinician experience questionnaire resultsTerminatedsponsor's stated reason: COVID pandemic / Change in strategic directionDevice: Barco NV Digital Dermatoscope device images, Standard medical photographs including dermoscopy images · Other: Clinic proforma completionSkin Cancer, Dermatology/Skin - Other132020-03-17actual2021-12-29

Primary completion is the date the sponsor filed with the registry — their own projection, revised whenever they revise it, unless the row is marked actual.

Source: ClinicalTrials.gov, retrieved 2026-08-19